Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
2
×
boston top stories
life sciences
national blog main
national top stories
akcea therapeutics
alnylam pharmaceuticals
anylam pharmaceuticals
beijing
biotech
brii bio
brii biosciences
cardiomyopathy
china
clinical trials
deals
drugs
glaxosmithkline
gsk
hepatitis b
inotersen
neuropathy
new york
new york blog main
new york top stories
onpattro
patisiran
pfizer
raleigh-durham
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
startups
tafamidis
tegsedi
transthyretin amyloidosis
tsinghua university
vbi vaccines
What
disease
2
×
drug
medicines
year
2
×
adds
ago
akcea
alliance
alnylam
amyloidosis
approved
areas
attr
available
battle
biosciences
bio’s
brii
debilitating
earlier
fda
genetic
hepatitis
infectious
launched
million
mission
new
oks
patients
pfizer
pipeline
rare
sets
therapeutic
transthyretin
vaccines
vbi
Language
Current search:
disease
×
year
×
" boston blog main "
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
